IDXX
IDEXX Laboratories, Inc. · Healthcare
President and CEO Jonathan Jay Mazelsky sold $6.9M of IDEXX Laboratories, Inc.
Sold$6,871,319
$572.61Price
12,000Shares
−13%Stake
What IDXX did after the filing
- The stock from Fri, Feb 9 close, $572.21
- −7.4%
- S&P 500, same days
- +4.0%
Measured over 30 trading days, to the Mar 25 close.
Traded Wed, Feb 7. Filed Fri, Feb 9, 12:00 PM ET, during the session. Returns use the Feb 9 close and the Mar 25 close. Not investment advice.